CClinicalTrials.gg
RecruitingNCT05954299Updated Dec 7, 2023

Vincere Biobank Research Protocol

An observational study in Cancer, sponsored by Vincere Cancer Center. Recruiting at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-12-07.

Sponsored by Vincere Cancer Center · Observational

From the registry’s dates

  • Started Jul 2023; still recruiting 3 years 2 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
5,000
Ages
18 Years and older
Sex
All
01

Study summary

The Vincere Biobank aims to make quality biospecimens and associated clinical data available for research studies related to advancing medicine and improving care for patients, including cancer screening, treatment, and care.

02

Conditions studied

  • Cancer

Keywords

  • Cancer
  • Biobank
  • Biorepository
03

In context

Lead sponsor

Vincere Cancer Center is the lead sponsor of 3 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Adults age 18 years and older of any gender and demographic group, including both healthy participants and those with disease.

Inclusion criteria

  • 18 years of age or older; any gender
  • Able to donate a blood, urine, tissue, and/or other biospecimen sample
  • Able to provide informed consent to participate in the study

Exclusion criteria

Exclusion Criteria:

  • Minors, under the age of 18 years
  • Individuals who lack the capacity to give informed consent
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
5,000 participants (estimated)
Patient registry
No
Biospecimen retention
Samples with dna

Groups and cohorts

  • Normal

    Participants and donor samples without disease (ex: non-cancer)

  • Disease state or condition

    Participants and donor samples with known disease or condition (ex: cancer)

06

What researchers measure

Primary outcomes

  1. Biobank

    Collect quality biospecimens with associated clinical data for research studies related to improving medicine and care to the patient, including cancer screening, treatment, and care.

    Time frame: 10 years

07

Study locations

1 of 1 sites recruiting
  • Vincere Cancer Center
    Scottsdale, Arizona 85260, United States
    • Christine Lau, MD · Contact · drlau@vincerecancer.com · 480-306-5390
    • Vershalee Shukla, MD · Principal investigator
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 7, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05954299
Lead sponsor
Vincere Cancer Center
Responsible party
Sponsor
First posted
Jul 20, 2023
Start date
Jul 18, 2023
Primary completion
Dec 31, 2033 (estimated)
Completion
Dec 31, 2038 (estimated)
Last update
Dec 7, 2023

Study contacts

Christine Lau, MD
Contact
drlau@vincerecancer.com
480-306-5390
Vershalee Shukla, MD
principal investigator · Vincere Cancer Center

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion